Noom Med vs Hims 2026: GLP-1 Weight Loss Programs Compared
Noom Med vs Hims for GLP-1 weight loss in 2026 — compare pricing, coaching models, medication options, and clinical outcomes to find the right provider.
Written by Trimi Medical Team
Medically reviewed by Dr. Amanda Foster, MD
Last updated 2026-04-08
More on GLP-1 Provider Comparisons
Noom Med vs Hims: Coaching Bundle vs Medication-First Platform
If you are searching for noom vs hims weight loss options, you are comparing two fundamentally different approaches to GLP-1 therapy. Noom Med bundles its well-known behavioral coaching app with prescription semaglutide, positioning the medication as one piece of a larger habit-change program. Hims treats GLP-1 medication as the centerpiece and delivers it through a streamlined telehealth platform without a coaching layer. Both charge more than providers like Trimi that focus exclusively on affordable, clinically supervised GLP-1 access.
Noom Med vs Hims, defined: Noom Med is a prescription weight loss program that pairs compounded semaglutide ($149 to $209 per month) with Noom's behavioral psychology-based coaching app (which may cost an additional $32 to $70 per month). Hims is a telehealth platform offering compounded semaglutide at $149 to $199 per month and compounded tirzepatide at $199 to $299 per month, without a bundled coaching component. Both are legitimate telehealth providers, but their philosophies, pricing structures, and value propositions differ significantly.
The clinical evidence behind GLP-1 medications is strong and applies equally to both platforms. The STEP 1 trial demonstrated that semaglutide 2.4 mg produced a mean body weight loss of 14.9% over 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SURMOUNT-1 trial showed tirzepatide at the highest dose achieved 22.5% body weight reduction over 72 weeks (Jastreboff et al., NEJM, 2022). Whether you fill your prescription through Noom Med, Hims, or any other licensed provider, the pharmacological mechanism is identical.
Key Takeaway
Noom Med and Hims represent two different philosophies: coaching-plus-medication versus medication-first. Both charge a premium compared to focused providers. Trimi offers semaglutide at $99/mo and tirzepatide at $125/mo with no app fees, no coaching markup, and no contracts. See our cheapest GLP-1 guide for the full pricing landscape.
Noom Med vs Hims vs Trimi: Side-by-Side Comparison
The following table compares all three providers across the factors that matter most when choosing a GLP-1 weight loss program: cost, medication options, clinical support, and program model.
| Feature | Noom Med | Hims | Trimi |
|---|---|---|---|
| Semaglutide cost | $149-$209/mo | $149-$199/mo | $99/mo |
| Tirzepatide cost | Not widely available | $199-$299/mo | $125/mo |
| Separate app/coaching fee | $32-$70/mo possible | None | None |
| Total monthly cost (semaglutide) | $149-$279/mo | $149-$199/mo | $99/mo |
| Behavioral coaching | App-based CBT coaching | Not included | Clinical guidance |
| Daily lessons / habit tracking | Yes (via Noom app) | No | No |
| Contract commitment | Varies by plan | None (month-to-month) | None (month-to-month) |
| Provider specialization | Behavioral health + weight loss | Multi-category telehealth | Metabolic health specialist |
| Medication included in price | Yes (app fee may be separate) | Yes | Yes |
| Time to start medication | Days to weeks | Days | Days |
| 12-month total (semaglutide) | $1,788-$3,348 | $1,788-$2,388 | $1,188 |
| Best for | Patients who want coaching alongside medication | Simple, medication-focused GLP-1 access | Best value for clinical GLP-1 care |
Pricing Analysis: What You Actually Pay at Noom Med vs Hims
Understanding the true cost of Noom Med versus Hims requires looking beyond the headline medication price. Noom Med's pricing structure includes a potential secondary cost layer that Hims does not have, which can make direct comparisons misleading if you only look at the base medication fee.
Noom Med Pricing
Noom Med charges $149 to $209 per month for compounded semaglutide, depending on the dosage tier. This price covers the medication and basic provider oversight. However, the Noom behavioral coaching app that makes Noom Med distinctive is not always included in the medication price. Depending on your plan structure, the coaching app can cost an additional $32 to $70 per month. This means a Noom Med patient who wants both the medication and the full coaching experience could pay $181 to $279 per month total. Over twelve months, that ranges from $1,788 to $3,348 annually for semaglutide alone. Patients curious about potential issues should review our Noom Med side effects guide.
Hims Pricing
Hims uses a cleaner pricing model. Compounded semaglutide costs $149 to $199 per month and compounded tirzepatide costs $199 to $299 per month. These prices include the medication, provider consultation, and shipping with no separate fees. There is no app subscription fee, no coaching fee, and no hidden charges. Over twelve months on semaglutide, a Hims patient pays approximately $1,788 to $2,388 total. For detailed information on what to expect, see our Hims weight loss side effects guide.
Annual Cost Comparison
Twelve months on semaglutide: Noom Med costs $1,788-$3,348 (with coaching app), Hims costs $1,788-$2,388, and Trimi costs $1,188. The difference between Noom Med at its highest tier and Trimi is over $2,100 per year. Even Hims costs $600 to $1,200 more per year than Trimi. For a complete breakdown of affordable options, see our cheapest GLP-1 injections guide.
Why the Coaching App Adds Cost Without Changing Medication Efficacy
The fundamental question when evaluating Noom Med's pricing is whether the bundled coaching app changes your weight loss outcomes enough to justify paying $50 to $150 more per month than a focused provider. The medication itself works through direct pharmacological mechanisms: GLP-1 receptor activation suppresses appetite, slows gastric emptying, and modulates central nervous system hunger signaling. None of these mechanisms are enhanced or diminished by whether you complete daily coaching lessons in an app. The coaching may support long-term behavioral habits, but it does not make the semaglutide injection more effective.
The Coaching Debate: Does Noom's App Justify the Premium Over Hims?
Noom built its reputation on a behavioral coaching app grounded in cognitive behavioral therapy principles. The app delivers daily lessons, food logging tools, habit tracking, and personalized coaching messages designed to help users understand their eating patterns and build sustainable behaviors. When Noom added prescription GLP-1 medication through Noom Med, it positioned the program as a comprehensive solution combining pharmacology with behavioral psychology. This is Noom Med's core value proposition and the primary justification for its pricing premium.
Hims takes the opposite position: medication is the treatment, and the platform exists to deliver that treatment efficiently. There are no daily lessons, no food logging system, and no behavioral curriculum. The app provides prescription management, provider messaging, and weight tracking. For patients who find Noom's coaching approach helpful, this simplicity is a limitation. For patients who find behavioral coaching unnecessary or prefer self-directed approaches, the simplicity is an advantage because they are not paying for features they will not use.
The research on this question is nuanced. Wadden et al. studied the effect of adding intensive behavioral therapy to semaglutide treatment and found that behavioral intervention produced modestly greater weight loss than medication with standard care alone. However, the incremental benefit of behavioral therapy was substantially smaller than the difference between semaglutide and placebo (JAMA, 2021). This finding suggests that while behavioral support can add value, the medication itself is the primary driver of weight loss outcomes, and the coaching component is supplementary rather than essential.
An important practical consideration: you do not need to bundle coaching and medication from the same provider. Patients who want behavioral support can subscribe to Noom's standalone coaching app (or any other habit-tracking app) while getting their GLP-1 medication from a more affordable provider like Trimi. This decoupled approach often costs less than Noom Med's bundled program while giving you the same tools and the same medication.
The Decoupling Strategy
Get your GLP-1 medication from a specialized, affordable provider and subscribe to any coaching or habit-tracking app separately. A Noom app subscription ($32-$70/mo) plus Trimi semaglutide ($99/mo) totals $131-$169 per month, which can be less than Noom Med's bundled pricing. You get the same coaching, the same medication, and more flexibility.
Clinical Evidence: GLP-1 Efficacy Is Provider-Independent
The most important fact in the Noom Med versus Hims comparison is that the clinical evidence supporting GLP-1 medications applies identically regardless of which platform prescribes them. Semaglutide and tirzepatide produce weight loss through direct pharmacological action on GLP-1 receptors (and GIP receptors in the case of tirzepatide), and these mechanisms operate the same way whether the medication arrives from Noom Med, Hims, or any other licensed provider.
The landmark STEP 1 trial enrolled 1,961 adults with obesity or overweight and demonstrated that semaglutide 2.4 mg weekly produced a mean body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo. Participants receiving semaglutide also showed clinically meaningful improvements in waist circumference, systolic blood pressure, and glycated hemoglobin (Wilding et al., New England Journal of Medicine, 2021). A patient weighing 220 pounds could expect to lose approximately 33 pounds over the treatment period based on these trial averages.
The SURMOUNT-1 trial enrolled 2,539 adults and showed that tirzepatide at the highest dose (15 mg weekly) produced 22.5% mean body weight loss over 72 weeks, with 63% of participants achieving at least 20% body weight reduction (Jastreboff et al., New England Journal of Medicine, 2022). These results established tirzepatide as the most effective GLP-1-class therapy currently available. Notably, Hims offers tirzepatide while Noom Med's availability of tirzepatide remains limited, which is a meaningful distinction for patients seeking the more effective dual-agonist medication.
A third study directly relevant to the coaching debate: Wadden et al. examined whether adding intensive behavioral therapy to semaglutide improves outcomes beyond standard care. They found that structured behavioral intervention produced modestly greater weight loss when combined with semaglutide, but the incremental benefit was smaller than the difference between semaglutide and placebo (JAMA, 2021). This is a crucial finding for the Noom Med versus Hims decision because it suggests that coaching adds marginal value on top of medication, not transformative value. Patients should weigh this modest benefit against the price premium Noom Med charges for its bundled coaching experience.
Evidence Summary
Semaglutide: 14.9% body weight loss over 68 weeks (STEP 1, Wilding et al., 2021). Tirzepatide: up to 22.5% body weight loss over 72 weeks (SURMOUNT-1, Jastreboff et al., 2022). Behavioral therapy adds modest incremental benefit on top of medication (Wadden et al., JAMA, 2021). The medication is the primary determinant of outcomes regardless of provider. Learn more on our semaglutide and tirzepatide treatment pages.
Pros and Cons: Noom Med vs Hims
Noom Med: Strengths
Established behavioral coaching app built on cognitive behavioral therapy with years of development
Daily lessons, habit tracking, and food logging tools that promote long-term behavioral change
Integrated experience where coaching content and medication management live in one ecosystem
Strong user engagement model designed by behavioral psychologists
May help patients who need structured accountability beyond medication alone
Noom Med: Limitations
Total cost including the coaching app can reach $181 to $279 per month, significantly more than focused medication providers
Coaching app fee may be charged separately from the medication fee, creating confusing pricing
Behavioral coaching does not change the pharmacological efficacy of the GLP-1 medication
Tirzepatide availability is limited compared to platforms like Hims and Trimi
Cancellation terms vary by plan and some subscriptions auto-renew
The same coaching app can be purchased independently for less without the bundled medication markup
Hims: Strengths
Clean, all-inclusive monthly pricing with no separate app fees or coaching charges
Both semaglutide and tirzepatide available, giving patients access to the most effective GLP-1 options
Month-to-month billing with no long-term contracts or cancellation penalties
Fast onboarding process with medication delivery in days
Established telehealth infrastructure with a polished app experience
Transparent pricing model makes cost comparison straightforward
Hims: Limitations
No behavioral coaching, daily lessons, or structured habit-building tools
Provider interaction is primarily asynchronous messaging rather than dedicated consultations
Multi-category telehealth platform means less specialization in metabolic health
Monthly pricing is $50 to $100 more than the most affordable focused GLP-1 providers
Limited clinical depth compared to obesity medicine specialists
The Bottom Line: Choosing Between Noom Med, Hims, and Trimi
The right choice depends on how much value you place on behavioral coaching, how you prefer to structure your weight loss journey, and what you are willing to pay each month.
Choose Noom Med if you thrive with app-based coaching and will actively use it
Noom Med makes sense for patients who genuinely engage with daily lessons, food logging, and behavioral coaching modules. The app is one of the most sophisticated behavior-change tools available and has real value for people who use it consistently. However, the premium is only worth paying if you will use the coaching features regularly. If you subscribe and skip the daily content, you are paying extra for nothing. For step-by-step switching instructions if it is not for you, see our guide to canceling Noom Med.
Choose Hims if you want straightforward medication access without coaching overhead
Hims is a solid choice for self-directed patients who want clean monthly pricing, access to both semaglutide and tirzepatide, and the flexibility to cancel anytime. The platform is efficient and the pricing is transparent. The downside is that Hims still costs $50 to $100 more per month than the most affordable providers, and the lack of clinical specialization in metabolic health may matter for patients with complex needs. See our guide on switching from Hims if you want to explore lower-cost alternatives.
Choose Trimi for the best value in clinically supervised GLP-1 therapy
Trimi offers semaglutide at $99 per month and tirzepatide at $125 per month with board-certified provider oversight, no contracts, and no supplementary fees. For patients who are primarily seeking effective, affordable medication with competent clinical supervision, Trimi saves $600 to $2,100 or more per year compared to Noom Med and Hims. Patients who want behavioral coaching can pair Trimi with any coaching app of their choice for a customized, cost-effective approach.
GLP-1 medications are a long-term treatment. Most patients take them for twelve months or longer to achieve and sustain meaningful weight loss results. The financial difference between providers compounds over time: Noom Med at its highest tier costs over $2,100 more per year than Trimi, and even Hims costs $600 to $1,200 more annually. Choosing a provider you can afford to stay with long enough for the medication to work is one of the most important decisions in your weight loss journey. Start with Trimi's free assessment to see if you qualify.
The smartest approach may be to separate your medication management from your behavioral tools. Get your GLP-1 prescription from the most affordable, clinically sound provider you can find, and invest in whatever coaching, therapy, or habit-tracking tools work for you independently. This gives you maximum flexibility, the best price on medication, and the freedom to change your behavioral support without disrupting your treatment. For cancellation guides if you are currently with either provider, see our Noom Med cancellation guide and Hims cancellation guide.
Frequently Asked Questions
Is Noom Med or Hims better for GLP-1 weight loss?
It depends on what you value. Noom Med bundles its behavioral coaching app with GLP-1 medication, which suits patients who want structured habit-building alongside their prescription. Hims offers a simpler medication-focused model at a slightly lower price. Neither platform changes how the medication itself works. Trimi offers the same medications starting at $99 per month for semaglutide with no coaching markup or contracts.
How much does Noom Med cost compared to Hims?
Noom Med charges $149 to $209 per month for semaglutide, and the Noom behavioral coaching app may cost an additional $32 to $70 per month depending on your plan. Hims charges $149 to $199 per month for semaglutide and $199 to $299 per month for tirzepatide. Trimi offers semaglutide at $99 per month and tirzepatide at $125 per month with no separate app fees or contracts.
Does Noom's coaching app actually improve GLP-1 weight loss results?
Noom's behavioral coaching app is based on cognitive behavioral therapy principles and can help patients build sustainable habits. However, research shows that the medication is the dominant driver of weight loss outcomes. Wadden et al. found that adding intensive behavioral therapy to semaglutide produced only modestly greater weight loss than medication with standard care (JAMA, 2021). The coaching may support long-term habit formation, but it does not change the pharmacological efficacy of GLP-1 medications.
Can I use Noom's app separately from my GLP-1 provider?
Yes. You can subscribe to Noom's behavioral coaching app independently and get your GLP-1 medication from a separate provider like Trimi. This approach lets you access Noom's habit-building tools while getting medication at a lower cost. The Noom app subscription is significantly cheaper on its own than the bundled Noom Med program.
Does Hims offer tirzepatide? Does Noom Med?
Hims offers both compounded semaglutide ($149 to $199 per month) and compounded tirzepatide ($199 to $299 per month). As of early 2026, Noom Med's GLP-1 program primarily focuses on semaglutide. Trimi offers both semaglutide at $99 per month and tirzepatide at $125 per month.
What happens if I want to cancel Noom Med or Hims?
Hims operates on month-to-month billing and you can cancel at any time without penalties. Noom Med cancellation terms vary by plan, and some subscriptions auto-renew or have specific cancellation windows. Review your plan terms carefully. See our guides on canceling Noom Med and canceling Hims for step-by-step instructions.
Which provider offers the best value for GLP-1 weight loss?
On a pure cost-per-month basis, Trimi offers the lowest pricing at $99 per month for semaglutide and $125 per month for tirzepatide with no contracts or app fees. Hims offers a good medication-focused model at $149 to $199 per month. Noom Med's total cost including the coaching app ranges from $149 to $279 per month. The medication works the same regardless of provider, so the value question centers on whether bundled coaching justifies the price premium.
Sources & References
- Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." New England Journal of Medicine, 2021;384(11):989-1002.
- Jastreboff AM, et al. "Tirzepatide Once Weekly for the Treatment of Obesity." New England Journal of Medicine, 2022;387(4):327-340.
- Wadden TA, et al. "Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults with Overweight or Obesity." JAMA, 2021;325(14):1403-1413.
- Noom, Inc. Noom Med official pricing and program information. 2026.
- Hims & Hers Health, Inc. Official pricing and program information. 2026.
- Wegovy (semaglutide) prescribing information. U.S. Food and Drug Administration.
- Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration.
- FDA compounding regulation overview.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. Pricing and program details are approximate, based on publicly available information as of April 2026, and subject to change. Verify current pricing directly with each provider. This article was prepared by the Trimi Medical Team and reviewed by Dr. Amanda Foster, MD. Trimi is a competing provider; this comparison is presented fairly but readers should independently verify all claims.